SCHEDULE 13D/A: LanzaTech Secures $40 Million Preferred Stock Investment from Khosla Ventures, Plans Major Dilutive Financing and Reverse Stock Split

Sentiment:

Amendment to Beneficial Ownership Report


LanzaTech Global, Inc. has entered into an agreement with Khosla Ventures for a $40 million preferred stock issuance, alongside plans for a significant dilutive follow-on financing at $0.05 per share and a reverse stock split, subject to stockholder approval.

Capital raiseIssuance and sale of 20,000,000 shares of Series A Convertible Senior Preferred Stock for an aggregate purchase price of $40,000,000 to an entity controlled by certain Reporting Persons.Agreement to issue Warrants to purchase 780,000,000 shares of Common Stock by May 31, 2025, at an exercise price of $0.0000001 per share.Commitment to use reasonable best efforts to consummate a 'Subsequent Financing' of Common Stock to accredited investors at $0.05 per share, aiming to raise between $35,000,000 and $60,000,000, contingent on stockholder approvals.
Worse than expectedThe planned 'Subsequent Financing' at $0.05 per share (pre-reverse split) implies a very low valuation for the common stock, which is significantly worse than what existing shareholders would typically expect.The necessity of a reverse stock split, often a measure to avoid delisting or to make shares more appealing at a higher nominal price, generally signals underlying financial weakness and is perceived negatively by the market.The massive potential dilution from the 780,000,000 warrants at a nominal exercise price, combined with the preferred stock conversion, indicates a substantial transfer of value and control to the new investor at the expense of existing common shareholders.

Summary

  • LanzaTech Global, Inc. (the 'Issuer') has filed an Amendment No. 1 to its Schedule 13D, detailing new financing arrangements with Khosla Ventures entities (the 'Reporting Persons').
  • On May 7, 2025, the Issuer sold 20,000,000 shares of Series A Convertible Senior Preferred Stock to an entity controlled by certain Reporting Persons for an aggregate purchase price of $40,000,000.
  • Each share of Preferred Stock is convertible into one share of Common Stock and carries three votes per Common Stock equivalent, granting significant voting power to the Preferred Stock holders.
  • The Preferred Stock includes extensive protective provisions, restricting the Company's ability to undertake various actions without consent, such as further financing, amending bylaws, issuing new equity, incurring debt, or changing executive compensation.
  • The Company also agreed to issue warrants by May 31, 2025, to purchase 780,000,000 shares of Common Stock at an exercise price of $0.0000001 per share, exercisable upon stockholder approvals and a subsequent financing.
  • LanzaTech is required to convene a stockholder meeting within 60-90 days of May 7, 2025, to obtain approvals for the issuance of shares related to the Preferred Stock, Warrants, and a Subsequent Financing, as well as to effect a reverse stock split and amend its certificate of incorporation.
  • A 'Subsequent Financing' is planned, where the Company will sell Common Stock to accredited investors at a price of $0.05 per share (subject to adjustment for the reverse stock split), aiming to raise between $35,000,000 and $60,000,000.
  • Khosla Ventures, through Vinod Khosla, beneficially owns 62,867,361 shares of Common Stock, representing 25.0% of the class, including the 20,000,000 shares issuable from the Preferred Stock conversion.
  • The Reporting Persons have agreed to vote their pre-Closing Date shares in favor of the Requisite Stockholder Approvals.

Sentiment

Score: 2

Explanation: The sentiment is highly negative for existing common shareholders due to the significant dilution implied by the very low share price of the subsequent financing, the massive warrant issuance, and the necessity of a reverse stock split. While capital is being raised, the terms are highly unfavorable, indicating a distressed valuation and substantial transfer of value to the new investor.

Positives

  • LanzaTech has secured $40 million in new capital through the issuance of Series A Convertible Senior Preferred Stock, providing immediate liquidity.
  • The agreement includes a commitment for a potential 'Subsequent Financing' of $35 million to $60 million, which could further bolster the company's financial position, contingent on stockholder approvals.

Negatives

  • The planned 'Subsequent Financing' at $0.05 per share (pre-reverse split) implies a significantly low valuation for the company's common stock, indicating substantial dilution for existing shareholders.
  • The necessity of a reverse stock split, mutually acceptable to the Company and Preferred Stock holders, often signals financial distress or a need to meet listing requirements, and can be perceived negatively by the market.
  • The issuance of warrants to purchase 780,000,000 shares at an extremely low exercise price ($0.0000001) represents a massive potential for future dilution.
  • The Preferred Stock holders have extensive protective provisions, including veto rights over future financings, equity issuances, debt, and material business changes, which could limit the Company's operational and strategic flexibility.
  • The requirement for stockholder approval for key actions, including the reverse stock split and the dilutive subsequent financing, introduces execution risk.

Risks

  • Risk of not obtaining 'Requisite Stockholder Approvals' for the issuance of shares, reverse stock split, and subsequent financing, which could jeopardize the full capital raise plan.
  • Significant dilution risk for existing common stockholders due to the conversion of Preferred Stock, the exercise of Warrants, and the low-priced 'Subsequent Financing'.
  • Operational and strategic limitations imposed by the protective provisions granted to the Preferred Stock holders.
  • Market perception risk associated with a reverse stock split and a highly dilutive financing at a very low share price.
  • Potential for further downward pressure on common stock price due to the implied valuation from the financing terms.

Future Outlook

The document outlines a clear path for LanzaTech to raise additional capital through a 'Subsequent Financing' of $35 million to $60 million, contingent upon obtaining 'Requisite Stockholder Approvals' for the issuance of shares, a reverse stock split, and other corporate actions. The Company is required to convene a stockholder meeting within 60-90 days of May 7, 2025, to seek these approvals, and the subsequent financing is expected to close within 10 business days thereafter. The Warrants are expected to be issued by May 31, 2025, and will be exercisable upon the satisfaction of certain conditions, including the subsequent financing.

Management Comments

  • The Reporting Persons acquired the Preferred Stock solely for investment purposes and have no present plans to change the business, policies, management, structure, or capitalization of the Issuer, but reserve the right to do so.
  • The Reporting Persons may engage in discussions with other stockholders, management, and the Board concerning the Issuer's business, operations, governance, management, strategy, capitalization, and future plans.
  • The Reporting Persons intend to exercise their rights under the Investors Rights Agreement, Registration Rights Agreement, and Certificate of Designation, including the right to elect one director to the Company's Board.

Industry Context

This financing event for LanzaTech, a company focused on carbon capture and gas fermentation technologies, highlights the ongoing capital requirements typical for innovative, growth-stage companies in the clean energy and biotechnology sectors. Such companies often require substantial and sustained investment to scale operations, develop technologies, and bring products to market. The terms of this financing, particularly the low share price for the subsequent raise and the need for a reverse stock split, suggest that LanzaTech is facing significant valuation challenges, which can be common in capital-intensive industries with long development cycles and high market volatility.

Comparison to Industry Standards

  • The $0.05 per share price for the planned 'Subsequent Financing' is exceptionally low, indicating a distressed valuation compared to typical growth-stage financing rounds in the clean technology sector, which often see higher per-share valuations for companies with established technologies.
  • The requirement for a reverse stock split is a common mechanism for companies to maintain stock exchange listing compliance or to make their stock more attractive to institutional investors, but it often signals underlying financial weakness or a significant decline in market capitalization, unlike more robust companies in the sector that can raise capital at higher valuations without such measures.
  • The extensive protective provisions granted to Khosla Ventures as Preferred Stock holders, including veto rights over key corporate actions, are more typical of distressed or highly speculative investments where the investor demands significant control and downside protection, rather than standard growth equity investments in well-capitalized peers.
  • The issuance of warrants for 780,000,000 shares at a nominal exercise price represents a very high potential dilution percentage, which is significantly higher than typical warrant coverages seen in less distressed financing rounds for comparable companies in the renewable fuels or carbon capture space.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorNAOne director to be elected by holders of Preferred StockUpon election, for so long as Preferred Stock remains outstandingRight granted to Preferred Stock holders under the Investors' Rights Agreement.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Certificate of Incorporation AmendmentTo effect a reverse stock split, authorize sufficient Common Stock shares post-split, set Common Stock par value to the Warrant exercise price, and allow stockholder action by written consent.Upon 'Requisite Stockholder Approvals'Significant changes to capital structure and shareholder rights, potentially impacting stock liquidity and corporate decision-making flexibility.
Preferred Stock Protective ProvisionsRestrictions on the Company's ability to consummate financing, amend bylaws, create new equity, increase/decrease authorized shares, pay dividends, incur debt, sell material assets, or materially change business without Preferred Stock holder consent.May 7, 2025Grants substantial control and veto rights to Preferred Stock holders, potentially limiting the Company's future strategic and financial flexibility.
Voting RightsEach share of Preferred Stock is entitled to cast three votes per each share of Common Stock into which it is convertible, subject to limitations prior to 'Requisite Stockholder Approvals'.May 7, 2025Significantly increases the voting power of the Preferred Stock holders relative to common shareholders, enhancing their influence over corporate matters.

Related Party Transactions

  • The Series A Convertible Senior Preferred Stock Purchase Agreement was entered into between LanzaTech Global, Inc. and an entity controlled by certain of the Reporting Persons (Khosla Ventures entities), making it a related party transaction.

Stakeholder Impact

  • Shareholders: Face significant potential dilution from the Preferred Stock conversion, Warrant exercise, and the low-priced 'Subsequent Financing'. The reverse stock split will reduce the number of outstanding shares but not necessarily increase the aggregate market value proportionally, and may be perceived negatively.
  • Creditors: The capital raise provides additional liquidity, which could improve the company's ability to meet its obligations, but the terms of the preferred stock (e.g., protective provisions) could influence future debt financing terms.
  • Employees: The capital infusion may provide stability and funding for ongoing operations, potentially securing jobs, but the overall financial restructuring might create uncertainty.
  • Management: Will operate under increased oversight and potential restrictions due to the protective provisions granted to the Preferred Stock holders, limiting strategic flexibility.

Next Steps

  • The Company is required to issue Warrants to the Purchaser no later than May 31, 2025.
  • The Company must convene a meeting of its stockholders within 60 days (or 90 days if SEC review occurs) following May 7, 2025, to obtain 'Requisite Stockholder Approvals'.
  • Upon obtaining 'Requisite Stockholder Approvals', the Company will use its reasonable best efforts to consummate the 'Subsequent Financing' within 10 business days.
  • The Warrants will become exercisable and automatically exercised on a cashless, net-exercise basis once the 'Conditions to Exercise' (stockholder approvals and subsequent financing) are satisfied.

Key Dates

DateDescription
2023-02-08Initial Schedule 13D filing date.
2025-04-21Date as of which 197,900,285 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-K/A.
2025-04-30Filing date of the Issuer's Form 10-K/A.
2025-05-07Closing Date of the Series A Convertible Senior Preferred Stock Purchase Agreement and the date of event requiring this filing.
2025-05-09Filing date of the Issuer's Current Report on Form 8-K, reporting conversion of Convertible Notes and details of the Preferred Stock issuance.
2025-05-12Signature date of the Schedule 13D Amendment No. 1 by the Reporting Persons.
2025-05-31Deadline for the Company to issue Warrants to the Purchaser.
2026-05-07Latest termination date for the Warrants, if not exercised earlier.

Recommendation

strong sell

Keywords

LanzaTech Global, Khosla Ventures, SEC filing, Schedule 13D, Preferred Stock, Convertible Notes, Warrants, Reverse Stock Split, Capital Raise, Dilution, Stockholder Approval, Corporate Governance, Financing Agreement, Clean Energy, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.